Revotar presents positive results in Phase IIa Ozone Study with Bimosiamose for COPD

Revotar presents positive results in Phase IIa Ozone Study with Bimosiamose for COPD HENNIGSDORF–(Marketwire – May 18, 2010) – Revotar Biopharmaceuticals AG / Revotar presents positive results in Phase IIa Ozone Study with Bimosiamose for COPD processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Study Shows Psoriasis Increases Risk of Miscarriage — Traditional Chinese Medicine (TCM) Effective Treatment for …

Study Shows Psoriasis Increases Risk of Miscarriage — Traditional Chinese Medicine (TCM) Effective Treatment for … A recent study shows the evidence for a link between miscarriage and psoriasis. Acubalance Wellness Centre presents a free public talk April 26 and 27 in Vancouver on how Chinese medicine can treat psoriasis, boost fertility and reduce the [...]